SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-22-002062
Filing Date
2022-11-28
Accepted
2022-11-28 17:03:31
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e4251_10k.htm   iXBRL 10-K 1362028
2 EXHIBIT 4.1 e4251_ex4-1.htm EX-4.1 14974
3 EXHIBIT 23.1 e4251_ex23-1.htm EX-23.1 2592
4 EXHIBIT 23.2 e4251_ex23-2.htm EX-23.2 3124
5 EXHIBIT 31.1 e4251_ex31-1.htm EX-31.1 16033
6 EXHIBIT 31.2 e4251_ex31-2.htm EX-31.2 19424
7 EXHIBIT 32.1 e4251_ex32-1.htm EX-32.1 6547
13 GRAPHIC image_001.jpg GRAPHIC 229749
14 GRAPHIC image_002.jpg GRAPHIC 94832
  Complete submission text file 0001731122-22-002062.txt   5339370

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE avxl-20220930.xsd EX-101.SCH 32548
9 XBRL CALCULATION FILE avxl-20220930_cal.xml EX-101.CAL 30896
10 XBRL DEFINITION FILE avxl-20220930_def.xml EX-101.DEF 100226
11 XBRL LABEL FILE avxl-20220930_lab.xml EX-101.LAB 256733
12 XBRL PRESENTATION FILE avxl-20220930_pre.xml EX-101.PRE 192778
47 EXTRACTED XBRL INSTANCE DOCUMENT e4251_10k_htm.xml XML 670196
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 221426387
SIC: 2836 Biological Products, (No Diagnostic Substances)